Department of Ophthalmology, Columbia University, New York, NY, USA.
Institute of Human Nutrition, Vagelos College of Physicians and Surgeons, New York, NY, USA.
Mol Genet Genomic Med. 2020 Jul;8(7):e1273. doi: 10.1002/mgg3.1273. Epub 2020 Apr 28.
The C677T variant of the MTHFR (5,10-Methylenetetrahydrofolate reductase) gene is associated with increased susceptibility to homocystinuria (OMIM#236250), neural tube defects (OMIM#601634), schizophrenia (OMIM#181500), thromboembolism (OMIM#188050), and vascular diseases. Protein S deficiency is also associated with an increased risk of thromboembolism from reduced thrombin generation. In this report, we describe the case of a patient who presented with multiple retinal vein occlusions likely caused by an underlying combination of a homozygous MTHFR C677T variant and protein S deficiency.
We performed 8 years of continuous ophthalmic follow-up of one patient diagnosed with central retinal vein occlusion. Peripheral blood was collected for metabolic evaluation and hypercoagulability assessment. Targeted gene sequencing was used for genetic diagnosis. Examination of the retinal vasculature was performed through dilated funduscopic examination, digital color fundus and ultrawide-field color fundus photography, spectral domain optical coherence tomography, and fluorescein angiography.
Sequential retinal vein occlusions and a transient ischemic attack were observed during the follow-up period. Targeted gene sequencing by PCR identified the homozygous MTHFR C677T variant. The metabolic profile indicated low-protein S activity, high levels of vitamin B6, and LDL cholesterol consistent with her hypercoagulable state. Prescription of low-dose aspirin and atorvastatin for hypercholesterolemia resulted in no further neovascularization, leakage, or vein occlusion.
Retinal vein occlusions associated with the MTHFR C677T variant and protein S deficiency may signal impending systemic thromboembolic episodes and warrant aggressive preventative measures.
MTHFR(5,10-亚甲基四氢叶酸还原酶)基因的 C677T 变体与高同型半胱氨酸血症(OMIM#236250)、神经管缺陷(OMIM#601634)、精神分裂症(OMIM#181500)、血栓栓塞(OMIM#188050)和血管疾病易感性增加有关。蛋白 S 缺乏也与由于凝血酶生成减少导致的血栓栓塞风险增加有关。在本报告中,我们描述了一名患者的病例,该患者因纯合 MTHFR C677T 变体和蛋白 S 缺乏的潜在组合而出现多发性视网膜静脉阻塞。
我们对一名被诊断为中心性视网膜静脉阻塞的患者进行了 8 年的连续眼科随访。采集外周血进行代谢评估和高凝状态评估。通过聚合酶链反应进行靶向基因测序进行基因诊断。通过散瞳眼底检查、数字眼底彩色照片和超广角彩色眼底照相、谱域光相干断层扫描和荧光素血管造影检查对视网膜血管进行检查。
在随访期间观察到连续的视网膜静脉阻塞和短暂性脑缺血发作。通过 PCR 进行的靶向基因测序确定了 MTHFR C677T 变体的纯合性。代谢谱表明蛋白 S 活性低、维生素 B6 水平高和 LDL 胆固醇水平高,符合她的高凝状态。低剂量阿司匹林和阿托伐他汀治疗高胆固醇血症后,没有新的新生血管形成、渗漏或静脉阻塞。
MTHFR C677T 变体和蛋白 S 缺乏相关的视网膜静脉阻塞可能预示着即将发生的全身性血栓栓塞事件,需要采取积极的预防措施。